IL178276A0 - Dimeric tat antigen and the use thereof for anti-hiv vaccination - Google Patents

Dimeric tat antigen and the use thereof for anti-hiv vaccination

Info

Publication number
IL178276A0
IL178276A0 IL178276A IL17827606A IL178276A0 IL 178276 A0 IL178276 A0 IL 178276A0 IL 178276 A IL178276 A IL 178276A IL 17827606 A IL17827606 A IL 17827606A IL 178276 A0 IL178276 A0 IL 178276A0
Authority
IL
Israel
Prior art keywords
hiv vaccination
tat antigen
dimeric
dimeric tat
antigen
Prior art date
Application number
IL178276A
Original Assignee
Commissariat Energie Atomique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat Energie Atomique filed Critical Commissariat Energie Atomique
Publication of IL178276A0 publication Critical patent/IL178276A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL178276A 2004-04-01 2006-09-25 Dimeric tat antigen and the use thereof for anti-hiv vaccination IL178276A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0403430A FR2868319B1 (en) 2004-04-01 2004-04-01 TAT DIMERIC ANTIGEN AND ITS APPLICATIONS FOR ANTI-HIV VACCINATION
PCT/FR2005/000796 WO2005097180A1 (en) 2004-04-01 2005-04-01 Dimeric tat antigen and the use thereof for anti-hiv vaccination

Publications (1)

Publication Number Publication Date
IL178276A0 true IL178276A0 (en) 2006-12-31

Family

ID=34944742

Family Applications (1)

Application Number Title Priority Date Filing Date
IL178276A IL178276A0 (en) 2004-04-01 2006-09-25 Dimeric tat antigen and the use thereof for anti-hiv vaccination

Country Status (3)

Country Link
FR (1) FR2868319B1 (en)
IL (1) IL178276A0 (en)
WO (1) WO2005097180A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102405057B (en) * 2009-03-23 2016-05-25 那尼尔科斯治疗公司 By immunostimulating Hiv Tat derivative polypeptides treatment cancer

Also Published As

Publication number Publication date
FR2868319A1 (en) 2005-10-07
FR2868319B1 (en) 2006-07-07
WO2005097180A1 (en) 2005-10-20

Similar Documents

Publication Publication Date Title
ZA200507067B (en) Antibodies against human IL-21 receptor and uses therefor
PL1812058T3 (en) Chlamydia trachomatis antigens for vaccine and diagnostic use
HK1179855A1 (en) Tuberculosis vaccines comprising antigens expressed during the latent infection phase
HK1107058A1 (en) Gas barrier film for medical use and medical bags made by using the same
EP1781327A4 (en) Identifying virally infected and vaccinated organisms
PL1765793T3 (en) Anacetrapib and other cetp inhibitprs
IL178402A0 (en) 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
IL184288A0 (en) 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same
EP1835027A4 (en) Novel cancer antigen peptide and the use thereof
IL178311A0 (en) Stabilised tat antigen and the use thereof for anti-hiv vaccination
IL177223A0 (en) Tat complexes and vaccines containing the same
IL180229A0 (en) PROTEIN COMPLEX CONTAINING A HEMAGGLUTININ AND A POLYPEPTIDE-Hc-CONJUGATE AND METHODS FOR THE PREPARATION THEREOF
GB0411150D0 (en) Vaccine
ZA200801874B (en) Antigenic peptides and their use
ZA200803664B (en) Chimeric antigens and vaccines
ZA200701496B (en) Post-foaming dental mousse and methods utilizing the same
ZA200711150B (en) Tuberculosis vaccines comprising antigens expressed during the latent infection phase
ZA200700507B (en) Identifying virally infected and vaccinated organisms
IL178276A0 (en) Dimeric tat antigen and the use thereof for anti-hiv vaccination
IL181228A0 (en) Vlp-antigen conjugates and their uses as vaccines
SG119341A1 (en) Novel bacterium and vaccine
EP1687022A4 (en) Renta: an hiv immunogen and uses thereof
EP1578461A4 (en) Vaccines against hiv-1 tat protein to generate neutralizing antibodies
GB0308691D0 (en) Vaccine preparations
EP1617865A4 (en) Enhanced hiv-1 vaccines and methods for their use